Please login to the form below

Not currently logged in

Lucid Group promotes Sally Stringer to managing partner of HealthCare21

Healthcare comms company has also announced an additional two new promotions

Lucid Group has promoted Sally Stringer (pictured above) to managing partner of its HealthCare21 team.

Stringer joined the HealthCare21 team in 2013 as an editorial team leader, before taking on the roles of scientific director and subsequently executive scientific director.

Prior to this, she worked as a senior medical writer at Prime-Medica. Stringer is also an honourary senior lecturer at Manchester University.

"I am thrilled to be taking the helm, to ensure the HealthCare21 team continues to inspire and invigorate our clients, maintain our values and drive positive transformation within healthcare,” said Stringer.

Lucid also announced two other promotions for new roles. Tanya Goodyear and Cheryl Harrison Doyle have been appointed as director of innovation and technology and global asset strategy director, respectively.

Before taking on her new role, Goodyear served as managing partner for Lucid Group’s medcomms team – Origins – while Harrison Doyle previously worked as client partnership director.

“I have been with Lucid Group now for more than 11 years and I am delighted and honoured to have the opportunity of pioneering a new capability within the organisation.  This role is fundamental in supporting our continued success, both within and beyond medical communications,” said Harrison Doyle.

Article by
Lucy Parsons

7th April 2021

From: Marketing


Subscribe to our email news alerts


Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
The rise of digital healthcare – fuelled by open innovation in healthtech hubs
How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...